This is a biased opinion as I truly believe the Psychedelic stock market will be expanding more and more in the years to come. Hence my long term bullish approach. Mindmed has been in a downtrend since Q3 21. Early February, price was rejected at yearly open. I do not think this reflects the company value but rather a market sentiment. Earnings early march might give some volume.
Investment thesis is as follow: I want to support companies that are working towards a better understanding of mental health issues, but I want my support to be as efficient as possible considering the economic uncertainties that surrounds the global market.
Either price reclaim yearly open if XBI and IWM rally/bounce
Downfall across the market continues--> buying between 55-80cent/share for best r:r